Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gland Pharma Limited
GLANDCurrent price
1 774 INR
+70.61 INR (+4.14%)
Last closed
1 703.4 INR
Company
www.glandpharma.com
ISIN
INE068V01023
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
300 721 429 812 INR
Yield for 12 month
+8.91 %
1Y
3Y
5Y
10Y
15Y
GLAND
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd. Address: Plot No. 11 & 84, TSIIC Phase: IV, Hyderabad, India, 502307
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
145 381.45 INRP/E ratio
43.4934Dividend Yield
1.13 %Current Year
+56 670 430 423 INR
Last Year
+36 260 861 270 INR
Current Quarter
+14 064 090 183 INR
Last Quarter
+14 022 843 345 INR
Current Year
+16 608 642 398 INR
Last Year
+19 399 685 530 INR
Current Quarter
+3 615 070 585 INR
Last Quarter
+3 435 867 188 INR
Key Figures GLAND
1 year
3 years
5 years
10 years
EBITDA
12 577 791 734 INR
Operating Margin TTM
PE Ratio
43.4934
Return On Assets TTM
5.27 %
PEG Ratio
–
Return On Equity TTM
8.09 %
Wall Street Target Price
145 381.45 INR
Revenue TTM
58 925 613 494 INR
Book Value
533.84 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.4 %
Dividend Yield
1.13 %
Gross Profit TTM
17 658 622 414 INR
Earnings per share
41.97 INR
Diluted Eps TTM
41.97 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-15.7 %
Profit Margin
11.74 %
Dividend Analytics GLAND
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GLAND
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
20
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
1.13 %
Last Split Factor
–
Payout Ratio
47.63 %
Last Split Date
–
Dividend Date
–
Stock Valuation GLAND
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
43.4934
Forward PE
51.2821
Enterprise Value Revenue
4.5478
Price Sales TTM
5.1034
Enterprise Value EBITDA
18.2419
Price Book MRQ
3.3325
Financials GLAND
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLAND
For 52 weeks
1 586.35 INR
2 199.3 INR
50 Day MA
1 765.21 INR
Shares Short Prior Month
–
200 Day MA
1 841.33 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart